Aspects of haemophilia prophylaxis in Sweden

Summary.  Prophylactic treatment of haemophilia has been gaining acceptance as the optimal therapeutic option in an increasing number of haemophilia centres in the developed world in recent years. This paper focus on three aspects of prophylactic therapy: when to start treatment, venous access and the dose/dose interval. Evidence is in favour of prophylactic treatment to be started at an early age using either a peripheral vein with 1–2 injections per week and a successive increase in the frequency depending on the child and the veins, or, using a Port‐A‐Cath which allows a better prophylactic coverage by infusions preferably every second day in haemophilia A and every third day in haemophilia B.

[1]  M. Siimes,et al.  Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries , 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

[2]  Ljung.  Second Workshop of the European Paediatric Network for Haemophilia Management, 17–19 September 1998 in Vitznau/Switzerland , 1999, Haemophilia : the official journal of the World Federation of Hemophilia.

[3]  J. Astermark,et al.  Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized , 1999, British journal of haematology.

[4]  R. Ljung,et al.  Port‐A‐Cath usage in children with haemophilia: experience of 53 cases , 1998, Acta paediatrica.

[5]  C. Kessler,et al.  When should prophylactic treatment in patients with haemophilia A and B start?— The German experience , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  J. Sanders,et al.  Implantable venous access devices in children with hemophilia: a report of low infection rates. , 1998, The Journal of pediatrics.

[7]  H. Pettersson,et al.  Haemophilia prophylaxis in young patients–a long‐term follow‐up , 1997, Journal of internal medicine.

[8]  K. Khair,et al.  The impact of prophylactic treatment on children with severe haemophilia , 1996, British journal of haematology.

[9]  E. Berntorp.  Methods of haemophilia care delivery: regular prophylaxis versus episodic treatment , 1995, Haemophilia : the official journal of the World Federation of Hemophilia.

[10]  H. Pettersson,et al.  A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs , 1994, Journal of internal medicine.

[11]  W. Schramm.  Experience with prophylaxis in Germany. , 1993, Seminars in hematology.

[12]  R. Ljung,et al.  Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia , 1992, Acta paediatrica.

[13]  H. Pettersson,et al.  Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B , 1992, Journal of internal medicine.

[14]  M. Blombäck,et al.  Prophylaxis with factor concentrates in preventing hemophilic arthropathy. , 1991, The American journal of pediatric hematology/oncology.

[15]  H. Pettersson,et al.  RADIOLOGIC EVALUATION OF PROPHYLAXIS IN SEVERE HAEMOPHILIA , 1981, Acta paediatrica Scandinavica.

[16]  M. Blombäck,et al.  ARTHROPATHY IN CHILDREN WITH SEVERE HEMOPHILIA A , 1980, Acta paediatrica Scandinavica.

[17]  Å. Ahlberg,et al.  HAEMOPHILIA PROPHYLAXIS IN SWEDEN , 1976, Acta paediatrica Scandinavica.

[18]  S. Rapaport,et al.  Hemophilia prophylaxis with factor VIII concentrate. , 1970, Archives of internal medicine.